肿瘤药物疗效Meta分析摘要对PRISMA-A的依从性及报告质量欠佳:一项文献调查
该文献调查评估了3211篇肿瘤药物疗效Meta分析摘要对PRISMA-A的依从性,平均总分为8.11(±1.76),依从率为57.94%。资助(0.93%)、注册(3.86%)和偏倚风险(7.85%)条目依从率最低。PRISMA-A发布后发表的Meta分析依从性更好,结构化摘要各条目依从率更高,摘要字数与总分呈正相关(r=0.358,P<.001)。
要点
- 肿瘤药物疗效Meta分析摘要对PRISMA-A的依从性欠佳,平均总分8.11(±1.76),依从率57.94%。
- 资助、注册和偏倚风险条目的依从率最低,分别为0.93%、3.86%和7.85%。
- PRISMA-A发布后发表的Meta分析依从性更好,结构化摘要各条目依从率更高。
核心结论
- 肿瘤药物疗效Meta分析摘要对PRISMA-A的依从性欠佳,尽管在PRISMA-A发布后有所改善。
- 作者建议采取多种措施提高对PRISMA-A的依从性并改善Meta分析摘要的报告,包括期刊采纳PRISMA-A、要求更严格遵循PRISMA-A、放宽摘要字数限制等。
研究设计与样本
- 文献调查,共评估3211篇符合条件的肿瘤药物疗效Meta分析摘要,采用改编自PRISMA-A声明的检查表进行评估。
- 依从性通过PRISMA-A总分和依从率(AR)分析;采用独立样本t检验比较两组特征的总分差异,多组比较采用方差分析或Kruskal-Wallis检验;采用Pearson相关系数衡量摘要字数与PRISMA-A总分的相关性。
主要发现
- 平均总分为8.11(±1.76),依从率为57.94%。
- 依从率较低的条目为资助(AR=0.93%)、注册(AR=3.86%)和偏倚风险(AR=7.85%)。
- PRISMA-A发布后发表的Meta分析对PRISMA-A的依从性更好。
- 与无结构摘要相比,结构化摘要在PRISMA-A各条目上依从率更高。
- 摘要字数与PRISMA-A总分呈正相关(r=0.358,P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the reporting of meta-analysis abstracts on drug efficacy for tumors in terms of adherence to Preferred Reporting Items for Systematic Reviews and Meta-analyses for Abstracts (PRISMA-A) and identify the potential factors associated with adherence to PRISMA-A. STUDY DESIGN AND SETTING: A total of 3,211 eligible meta-analysis abstracts were assessed using a checklist adapted from the PRISMA-A statement. Adherence to PRISMA-A was analyzed by the total PRISMA-A score and adherence rate (AR). The independent samples t-test was performed to compare the difference of the total scores between two groups with different characteristics, and the analysis of variance or Kruskal-Wallis test was used among multiple groups. The Pearson's correlation coefficient was used to measure the correlation between the word count and the total PRISMA-A score. RESULTS: The mean total score was 8.11 (±1.76) and the AR was 57.94%. The items with lower AR were funding (AR = 0.93%), registration (AR = 3.86%), and risk of bias (AR = 7.85%). Meta-analyses published after the release of PRISMA-A showed better adherence to PRISMA-A. Compared to unstructured abstracts, structured abstracts had a higher AR for each item in PRISMA-A. There was a positive correlation between the word count of abstract and the total PRISMA-A score (r = 0.358, P < .001). CONCLUSION: Adherence to PRISMA-A was suboptimal in meta-analysis abstracts on drug efficacy for tumors, despite the improvement after the release of PRISMA-A. Various measures should be implemented to improve compliance with PRISMA-A and enhance the reporting of meta-analysis abstracts, including journal endorsement of PRISMA-A, requirement of stricter adherence to PRISMA-A, relaxation of abstract word limits, etc.
引用
- Yan B, Li M, Zhang J, et al. Adherence to PRISMA-A and reporting was suboptimal in meta-analysis abstracts on drug efficacy for tumors: a literature survey. J Clin Epidemiol. 2024. PMID: 39178995. doi:10.1016/j.jclinepi.2024.111506
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。